| Autor: |
Klein1, Michael, 2, Geoghegan1, Justin, Schmidt1, Karl, Böckler1, Dittmar, Korn3, Klaus, Wittekind4, Christian, Scheele1, Johannes |
| Zdroj: |
Transplantation; July 1997, Vol. 64 Issue: 1 |
| Abstrakt: |
Recurrent hepatitis B infection after liver transplantation is associated with poor graft and patient survival. Famciclovir is a nucleoside with virostatic action in hepatitis B infection. We report the case of a 51-year-old patient who developed recurrent delta-positive hepatitis B infection after liver transplantation. After famciclovir treatment, he became seronegative for hepatitis B early and hepatitis B surface antigens and developed protective anti-hepatitis B surface antibody titers. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
